Please assess the completion status of the following clinical trial:

Trial Title: Exploratory Study of the Cutaneous Penetration of Biodegradable Polymeric Microparticles in Atopic Dermatitis

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: EARLY_PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy volunteers:~  * Volunteers over 18~ * Male volunteers under 65 or women of childbearing age (with a negative pregnancy test obtained at least 3 weeks before inclusion)~ * Caucasian volunteers~ * Volunteers having never shown any type of skin lesions regardless of its origin especially any allergic skin reactions.~ * Volunteers having signed a free and informed consent form~ * Volunteers affiliated to a social security system~* Patients:~  * Patients over 18~ * Male patients under 65 or women of childbearing age (with a negative pregnancy test obtained at least 3 weeks before inclusion)~ * Caucasian patients~ * Acute phase of atopic dermatitis with a SCORAD between 15 and 40~ * Patients suffering from atopic dermatitis skin lesions ≥ 1.5 cm² on the inside of the forearm~ * Patients having been treated by class II dermocorticoids with a two-week wash-out prior to inclusion~ * Patients having signed a free and informed consent form~ * Patients affiliated to a social security system~Exclusion Criteria:~* Participants under 18~* Pregnant or Breastfeeding women~* Post-menopausal women~* Patients having skin lesions adjacent to the selected area~* Patients with complications of atopic dermatitis~* SCORAD \<15 or \>40~* Patients being treated with a topical or a systemic treatment influencing the skin penetration of the microparticles~* Patients allergics to any component of the formulation~* Patients using cosmetic products on their forearms~* Patients planning to expose themselves to the sun~* Patients with a known immune deficiency~* Patients allergic to any product or device used before, during or after the skin biopsy~* Patients suffering from known wound healing disorders~* Patients with known inherited ou acquired hemostasis disorders~* Patients unable to follow the protocol requirements~* Patients currently involved in another clinical trial (or whose participation has ended less than 2 weeks before inclusion)~* Patients who are not affiliated to a social security system~* Patients in an exclusion period following participation in another clinical trial~* Incapacitated adults~* Participants placed under tutorship or curatorship~* Participants under judicial protection

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Group of healthy volunteers and group of patients (Type: EXPERIMENTAL): * Healthy volunteers: Microparticles will be applied to the skin of the forearm and then a skin biopsy of this area will be performed~* Patients suffering from atopic dermatitis: Microparticles will be applied to the skin of the forearm both to an area affected by dermatitis and to an area deprived from the disease. A skin biopsy of these two areas will be performed

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: enrollment issues